Bryan M. Reasons - Net Worth and Insider Trading

Bryan M. Reasons Net Worth

The estimated net worth of Bryan M. Reasons is at least $807,514 dollars as of 2024-04-28. Bryan M. Reasons is the CFO of Amneal Pharmaceuticals Inc and owns about 82,986 shares of Amneal Pharmaceuticals Inc (AMRX) stock worth over $487,128. Bryan M. Reasons is the Director of Societal CDMO Inc and owns about 291,049 shares of Societal CDMO Inc (SCTL) stock worth over $320,154. Bryan M. Reasons is also the EVP & CFO of Mallinckrodt PLC and owns about 11,593 shares of Mallinckrodt PLC (MNKKQ) stock worth over $232. Details can be seen in Bryan M. Reasons's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bryan M. Reasons has not made any transactions after 2023-08-28 and currently still holds the listed stock(s).

Transaction Summary of Bryan M. Reasons

To

Bryan M. Reasons Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bryan M. Reasons owns 5 companies in total, including Aclaris Therapeutics Inc (ACRS) , Societal CDMO Inc (SCTL) , and Mallinckrodt PLC (MNKKQ) among others .

Click here to see the complete history of Bryan M. Reasons’s form 4 insider trades.

Insider Ownership Summary of Bryan M. Reasons

Ticker Comapny Transaction Date Type of Owner
ACRS Aclaris Therapeutics Inc 2018-04-20 director
SCTL Societal CDMO Inc 2023-08-28 director
MNKKQ Mallinckrodt PLC 2022-06-16 EVP & CFO
AMRX Amneal Pharmaceuticals Inc 2018-08-21 CFO
MCKPF Mallinckrodt PLC 2022-06-16 EVP & CFO

Bryan M. Reasons Latest Holdings Summary

Bryan M. Reasons currently owns a total of 3 stocks. Among these stocks, Bryan M. Reasons owns 82,986 shares of Amneal Pharmaceuticals Inc (AMRX) as of August 21, 2018, with a value of $487,128 and a weighting of 60.32%. Bryan M. Reasons owns 291,049 shares of Societal CDMO Inc (SCTL) as of August 28, 2023, with a value of $320,154 and a weighting of 39.65%. Bryan M. Reasons also owns 11,593 shares of Mallinckrodt PLC (MNKKQ) as of December 3, 2020, with a value of $232 and a weighting of 0.03%.

Latest Holdings of Bryan M. Reasons

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMRX Amneal Pharmaceuticals Inc 2018-08-21 82,986 5.87 487,128
SCTL Societal CDMO Inc 2023-08-28 291,049 1.10 320,154
MNKKQ Mallinckrodt PLC 2020-12-03 11,593 0.02 232

Holding Weightings of Bryan M. Reasons


Bryan M. Reasons Form 4 Trading Tracker

According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 0 transactions in Amneal Pharmaceuticals Inc (AMRX) over the past 5 years. The most-recent trade in Amneal Pharmaceuticals Inc is the sale of 11,698 shares on August 21, 2018, which brought Bryan M. Reasons around $276,658.

According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 1 transactions in Societal CDMO Inc (SCTL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Societal CDMO Inc is the acquisition of 62,500 shares on August 28, 2023, which cost Bryan M. Reasons around $25,000.

According to the SEC Form 4 filings, Bryan M. Reasons has made a total of 2 transactions in Mallinckrodt PLC (MNKKQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Mallinckrodt PLC is the sale of 5,400 shares on December 3, 2020, which brought Bryan M. Reasons around $918.

Insider Trading History of Bryan M. Reasons

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bryan M. Reasons Trading Performance

GuruFocus tracks the stock performance after each of Bryan M. Reasons's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan M. Reasons is -46.57%. GuruFocus also compares Bryan M. Reasons's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan M. Reasons within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bryan M. Reasons's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bryan M. Reasons

Average Return

-69.64%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.39 -46.57 -29.46 -69.64 -80.52 -80.37
Relative Return to S&P 500(%) -2.92 -49.78 -41.38 -80.8 -101.77 -93.49

Bryan M. Reasons Ownership Network

Ownership Network List of Bryan M. Reasons

No Data

Ownership Network Relation of Bryan M. Reasons


Bryan M. Reasons Owned Company Details

What does Aclaris Therapeutics Inc do?

Who are the key executives at Aclaris Therapeutics Inc?

Bryan M. Reasons is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .

Aclaris Therapeutics Inc (ACRS) Insider Trades Summary

Over the past 18 months, Bryan M. Reasons made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net sale of 53,837 shares made by Joseph Monahan , a net sale of 129,240 shares made by Neal Walker , and a net purchase of 12,800 shares made by Douglas J. Manion .

In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 243,164 shares of Aclaris Therapeutics Inc (ACRS) were sold and 36,995 shares were bought by its insiders, resulting in a net sale of 206,169 shares.

Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aclaris Therapeutics Inc Insider Transactions

No Available Data

Bryan M. Reasons Mailing Address

Above is the net worth, insider trading, and ownership report for Bryan M. Reasons. You might contact Bryan M. Reasons via mailing address: C/o Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward Ca 94544.

Discussions on Bryan M. Reasons

No discussions yet.